Related references
Note: Only part of the references are listed.Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma
J. Hannay et al.
GENE THERAPY (2007)
Humoral immune responses against minute virus of mice vectors
Susanne I. Lang et al.
JOURNAL OF GENE MEDICINE (2006)
The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma
DJ Grunhagen et al.
CANCER (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
VSV-tumor selective replication and protein translation
GN Barber
ONCOGENE (2005)
Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus
K Shinozaki et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Eradication of advanced hepatocellular carcinoma in rats via repeated hepatic arterial infusions of recombinant VSV
K Shinozaki et al.
HEPATOLOGY (2005)
Vesicular stomatitis virus: re-inventing the bullet
BD Lichty et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus
K Shinozaki et al.
MOLECULAR THERAPY (2004)
Isolated limb perfusion: What is the evidence for its use?
EM Noorda et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model
V Tsai et al.
CLINICAL CANCER RESEARCH (2004)
Cultured autologous human cells for hard tissue regeneration: Preparation and characterization of mesenchymal stem cells from bone marrow
N Kotobuki et al.
ARTIFICIAL ORGANS (2004)
Vesicular stomatitis virus:: An exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?.
MA Giedlin et al.
CANCER CELL (2003)
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
AMM Eggermont et al.
LANCET ONCOLOGY (2003)
The complement response against an oncolytic virus is species-specific in its activation pathways
H Wakimoto et al.
MOLECULAR THERAPY (2002)
Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
D Kirn et al.
NATURE MEDICINE (2001)
Isolated limb perfusion for local gene delivery - Efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas
WK de Roos et al.
ANNALS OF SURGERY (2000)
Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant
K Ikeda et al.
JOURNAL OF VIROLOGY (2000)
Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney
XH Ye et al.
HUMAN GENE THERAPY (2000)
Share Paper
